106
Participants
Start Date
July 31, 2015
Primary Completion Date
June 6, 2017
Study Completion Date
June 6, 2017
Finasteride 23.5 mg tablets
Finasteride 33.5 mg tablets
Placebo tablets
Greenwich Village Dermatology, New York
Paddington Testing Co., Inc., Philadelphia
Invocare Clinical Research Center, West Columbia
Marietta Dermatology Clinical Research, Inc., Marietta
MedaPhase, Inc., Newnan
Park Avenue Dermatology, Orange Park
International Clinical Research, Sanford
Lenus Research & Medical Group, Sweetwater
Advanced Medcial Research Institiute, Miami Lakes
MOORE Clinical Research, Inc., Brandon
UHCMC Skin Study Center, Cleveland
The Indiana Clinical Trials Center, PC, Plainfield
Dawes Fretzin Clinical Research Group. LLC, Indianapolis
Hamzavi Dermatology, Fort Gratiot
Glazer Dermatology, Buffalo Grove
Summit Dermatology, Oakbrook Terrace
Northwestern University, Chicago
MediSearch Clinical Trials, Saint Joseph
Burke Pharmaceutical Research, Hot Springs
Horizons Clinical Research Center, LLC., Denver
Northwest Clinical Trials, Boise
Omni Dermatology, Inc., Phoenix
Axis Clinical Trials, Los Angeles
Dr. Ronald Moy, Beverly Hills
Orange County Research Center, Tustin
Elorac, Inc.
INDUSTRY